Koss-Olinger Consulting, LLC

Position in GSK — GSK plc

CIK 1861163 GAINESVILLE, FL

Position in GSK

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$229,075

-$2,450,068 QoQ

Shares Held

4,370

-91.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#680

of 1,033 holders

Holding Since

Sep 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Koss-Olinger Consulting, LLC holds $866,167 across 3 Drug Manufacturers - General names. GSK ranks #2 (26.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,649	$418,796
2	GSK	GSK plc This page	4,370	$229,075
3	LLY	ELI LILLY & Co	182	$218,296

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$229,075	4,370	-91.0%	Shares	Sole	2026-08-10
2026-03-31	$2,679,143	48,544	-0.9%	Shares	Sole	2026-05-07
2025-12-31	$2,402,028	48,981	-25.4%	Shares	Sole	2026-02-10
2025-09-30	$2,834,187	65,667	-0.1%	Shares	Sole	2025-10-20
2025-06-30	$2,524,262	65,736	-3.6%	Shares	Sole	2025-08-01
2025-03-31	$2,641,913	68,196	+0.3%	Shares	Sole	2025-05-12
2024-12-31	$2,298,711	67,969	+8.9%	Shares	Sole	2025-02-11
2024-09-30	$2,550,339	62,386	-0.8%	Shares	Sole	2024-10-21
2024-06-30	$2,420,918	62,881	+11.4%	Shares	Sole	2024-08-06
2023-12-31	$2,092,074	56,451	+7.1%	Shares	Sole	2024-02-13
2023-09-30	$1,910,991	52,717	+5.0%	Shares	Sole	2023-10-11
2023-06-30	$1,790,197	50,230	-1.6%	Shares	Sole	2023-07-31
2023-03-31	$1,816,359	51,050	+2.1%	Shares	Sole	2023-05-12
2022-12-31	$1,756,402	49,983	+193.2%	Shares	Sole	2023-02-14
2022-09-30	$501,722	17,048	+216.9%	Shares	Sole	2022-11-14
2022-06-30	$229,652	5,379	-26.3%	Shares	Sole	2022-07-08
2022-03-31	$311,839	7,299	+3.4%	Shares	Sole	2022-05-06
2021-12-31	$305,238	7,057	+0.2%	Shares	Sole	2022-02-07
2021-09-30	$263,833	7,040	—	Shares	Sole	2021-11-09
No filing history on record for this holder in this stock.